KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

News: KZA Kazia Therapeutics Entered Licensing Agreement With Simcere Pharmaceutical Group Ltd

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    29/03/21
    19:20
    Post #: 52122950

    March 29 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • ENTERED INTO LICENSING AGREEMENT WITH SIMCERE PHARMACEUTICAL GROUP LTD
    • AGREEMENT TO DEVELOP AND COMMERCIALISE CO'S NEW DRUG, PAXALISIB, IN GREATER CHINA
    • UNDER TERMS OF AGREEMENT, KAZIA WILL RECEIVE AN UPFRONT PAYMENT OF US$11 MILLION
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AHK New MRE update reveals significant resource uplift at Sandy Mitchell—discover the details
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Regulatory approval granted for drilling at high-grade lead and silver project—drilling set to begin soon
right-arrow Created with Sketch.
NEWS Large-scale copper discovery confirmed with high-grade assays—significant potential for major sedimentary-hosted copper deposits
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.